Ravishankar Srivastav and *Devendra Kumar Katiyar


Hypertension is the medical condition where the systolic blood pressure is more than 140 mm Hg and the diastolic blood pressure is more than 90 mm Hg. It is a chronic disease which is considered to be one of the major public health problems and a significant cardiovascular risk factor. Antihypertensives are a class of drugs that are used to treat hypertension (high blood pressure). Antihypertensive therapy seeks to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Achieving blood pressure goals usually requires two or more antihypertensive drugs; As the demand is increasing due to increased cases of hypertensive people , prevalence of adverse drug reactions (ADRs) has also increased. AIM: This study was aimed to monitor the adverse drug reactions (ADRs) caused by antihypertensive medicines prescribed. Materials and methods: A total of 500 patients were observed with an informed consent. ADRs experienced by patients and any other relevant history, including the pre-existing medical conditions. These ADRs were then assessed using WHO probability assessment (causality assessment) scale for adverse drug reactions. Results: A total of 42 cases of ADRs were observed in 500 hypertensive patients observed. On the causality scale of WHO, 19 (45.2%) ADRs were classified possible, 14 (33.3%) probable, 6 (14.2%) unlikely, 2(4.7%) certain and 1 (2.3%) were unclassifiable. The ADRs related to of individual drugs administered by the patients were also tabulated. Conclusion: To conclude we can say that this study gives an insight that antihypertensive drugs should be continuously monitored as they are related with many ADRs. This helps the physician in early documentation of the ADRs and this can definitely help in giood patient management.

Keywords: Hypertension is the medical in giood patient management.

[Full Text Article]   [Download Certificate]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    APRIL 2024 Issue has been successfully launched on 1 APRIL 2024.

  • EJBPS New Impact Factor

    EJBPS Impact Factor has been Increased to 7.482 for Year 2024.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction